Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1):e395–e400. doi: 10.1097/MEG.0000000000002113

Table 2.

Forward stepwise regression of factors associated with severe symptom(s)

Step 1 Step 2 Step 3 Step 4 Step 5

OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI)


Liver Frailty Index 1.4 (1.2–1.7) 1.4 (1.1–1.7) 1.3 (1.1–1.6) 1.3 (1.1–1.6) 1.3 (1.1–1.6)
MELDNa 1.1 (1.0–1.1) 1.1 (1.0–1.1) 1.1 (1.0–1.1) 1.1 (1.0–1.1)
Ascites 1.6 (0.7–3.4) 1.5 (0.7–3.2) 1.5 (0.7–3.3)
Hepatic encephalopathy 1.4 (0.7–2.9) 1.4 (0.7–2.9)
Age 1.0 (1.0–1.0)

per 0.5-unit increase

MELDNa=Model for End-Stage Liver Disease–sodium, CI=confidence ratio, OR= Odds ratio